ADSTEM
A phase I/II study to evaluate allogeneic mesenchymal stromal cells for the treatment of skin disease in adults with Recessive Dystrophic Epidermolysis Bullosa...
01 January, 2015
Archive
01 January, 2013
TALEN-based gene editing
A TALEN-based approach to developing safer, more effective treatments for people with Epidermolysis Bullosa...
01 October, 2012
EBSTEM
Clinical trial of mesenchymal stromal cells in Recessive Dystrophic Epidermolysis Bullosa...